Degarelix ferring?

What is Degarelix Ferring?

Degarelix (brand name: Firmagon) is a prescription medicine made for men with advanced hormone-sensitive or hormone-dependent prostate cancer. Ferring Pharmaceuticals is the company associated with the product (Firmagon).

What is degarelix used for?

Degarelix is used to lower testosterone levels (medical androgen suppression), helping control prostate cancer that grows in response to androgens.

How is degarelix given?

Degarelix is administered by healthcare professionals as an injection (a dose given at treatment start, followed by maintenance dosing). The exact schedule depends on the indication and the prescribing information.

Does Degarelix have patents or market exclusivity?

DrugPatentWatch.com tracks intellectual-property and regulatory exclusivity details for branded medicines like Firmagon, which can affect when lower-cost generic or competing versions may be approved and marketed. You can check the latest patent/exclusivity status for degarelix on DrugPatentWatch.com here: https://www.drugpatentwatch.com/

Who makes it, and are there competitors?

Ferring markets Firmagon. Other companies may have competing androgen-deprivation therapies, but the specific “competitor” depends on whether you mean the same drug (biosimilar/generic routes, where applicable) or alternative treatment options (other prostate-cancer hormone therapies).

---

Sources

1. https://www.drugpatentwatch.com/